1. |
Lim H, Devesa SS, Sosa JA, et al. Trends in thyroid cancer incidence and mortality in the united states, 1974-2013. JAMA, 2017, 317(13): 1338-1348.
|
2. |
Bychkov A, Hirokawa M, Jung CK, et al. Low rate of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in asian practice. Thyroid, 2017, 27(7): 983-984.
|
3. |
Chen L, Zhu Y, Zheng K, et al. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma. J Cancer Res Clin Oncol, 2017, 143(6): 1035-1042.
|
4. |
Rahaman SO, Sharma P, Harbor PC, et al. IL-13Rα2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res, 2002, 62(4): 1103-1109.
|
5. |
Fichtner-Feigl S, Strober W, Kawakami K, et al. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis. Nat Med, 2006, 12(1): 99-106.
|
6. |
Han J, Puri RK. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme. J Neurooncol, 2018, 136(3): 463-474.
|
7. |
Newman JP, Wang GY, Arima K, et al. Interleukin-13 receptor alpha 2 cooperates with EGFRvⅢ signaling to promote glioblastoma multiforme. Nat Commun, 2017, 8(1): 1913.
|
8. |
Meng M, Liao H, Zhang B, et al. Cigarette smoke extracts induce overexpression of the proto-oncogenic gene interleukin-13 receptor α2 through activation of the PKA-CREB signaling pathway to trigger malignant transformation of lung vascular endothelial cells and angiogenesis. Cell Signal, 2017, 31: 15-25.
|
9. |
Kwon HJ, Choi JE, Bae YK. Interleukin-13 receptor alpha 2 expression in tumor cells is associated with reduced disease-free survival in patients with luminal subtype invasive breast cancer. Tumour Biol, 2018, 40(6): 1010428318783657.
|
10. |
Bartolomé RA, Jaén M, Casal JI. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer. Br J Cancer, 2018, 119(8): 940-949.
|
11. |
Wanibuchi M, Kataoka-Sasaki Y, Sasaki M, et al. Interleukin-13 receptor alpha 2 as a marker of poorer prognosis in high-grade astrocytomas. J Neurosurg Sci, 2018, 62(3): 239-244.
|
12. |
Gu M. IL13Rα2 siRNA inhibited cell proliferation, induced cell apoptosis, and suppressed cell invasion in papillary thyroid carcinoma cells. Onco Targets Ther, 2018, 11: 1345-1352.
|
13. |
Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med, 2006, 203(9): 2201-2213.
|
14. |
Boldajipour B, Mahabaleshwar H, Kardash E, et al. Control of chemokine-guided cell migration by ligand sequestration. Cell, 2008, 132(3): 463-473.
|
15. |
Gu HQ, Zhang ZB, Zhang JW, et al. The role of the SDF-1/CXCR7 axis on the growth and invasion ability of endometrial cancer cells. Arch Gynecol Obstet, 2017, 295(4): 987-995.
|
16. |
Yuan CL, Liu ZH, Zou N, et al. Relationship between expression of CXCR7 and NF-κB in breast cancer tissue and occurrence of breast cancer and lymphatic metastasis. Saudi J Biol Sci, 2017, 24(8): 1767-1770.
|
17. |
Xue TC, Han D, Chen RX, et al. High expression of CXCR7 combined with alpha fetoprotein in hepatocellular carcinoma correlates with extra-hepatic metastasis to lung after hepatectomy. Asian Pac J Cancer Prev, 2011, 12(3): 657-663.
|
18. |
Benhadjeba S, Edjekouane L, Sauvé K, et al. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer. Mol Oncol, 2018, 12(10): 1689-1705.
|
19. |
Li XX, Zheng HT, Huang LY, et al. Silencing of CXCR7 gene represses growth and invasion and induces apoptosis in colorectal cancer through ERK and β-arrestin pathways. Int J Oncol, 2014, 45(4): 1649-1657.
|
20. |
Wu Y, Tian L, Xu Y, et al. CXCR7 silencing inhibits the migration and invasion of human tumor endothelial cells derived from hepatocellular carcinoma by suppressing STAT3. Mol Med Rep, 2018, 18(2): 1644-1650.
|
21. |
Singh RK, Lokeshwar BL. The IL-8-regulated chemokine receptor CXCR7 stimulates EGFR signaling to promote prostate cancer growth. Cancer Res, 2011, 71(9): 3268-3277.
|
22. |
Hao M, Zheng J, Hou K, et al. Role of chemokine receptor CXCR7 in bladder cancer progression. Biochem Pharmacol, 2012, 84(2): 204-214.
|
23. |
Liu Z, Sun DX, Teng XY, et al. Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma. Endocr Pathol, 2012, 23(4): 247-253.
|
24. |
Liu Z, Yang L, Teng X, et al. The involvement of CXCR7 in modulating the progression of papillary thyroid carcinoma. J Surg Res, 2014, 191(2): 379-388.
|
25. |
Zhang H, Yang L, Teng X, et al. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo. Tumour Biol, 2016, 37(2): 2415-2423.
|
26. |
Lin Y, Ma Q, Li L, et al. The CXCL12-CXCR4 axis promotes migration, invasiveness, and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling. Biochem Cell Biol, 2018, 96(5): 619-626.
|
27. |
Zhang H, Yang L, Liu Z, et al. iTRAQ-coupled 2D LC/MS-MS analysis of CXCR7-transfected papillary thyroid carcinoma cells: A new insight into CXCR7 regulation of papillary thyroid carcinoma progression and identification of potential biomarkers. Oncol Lett, 2017, 14(3): 3734-3740.
|
28. |
Ye XC, Hu JX, Li L, et al. Astrocytic Lrp4 (low-density lipoprotein receptor-related protein 4) contributes to ischemia-induced brain injury by regulating atp release and adenosine-A stroke, 2018, 49(1): 165-174.
|
29. |
Weatherbee SD, Anderson KV, Niswander LA. LDL-receptor-related protein 4 is crucial for formation of the neuromuscular junction. Development, 2006, 133(24): 4993-5000.
|
30. |
Ohno K, Ohkawara B, Ito M. Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders. Expert Opin Ther Targets, 2017, 21(10): 949-958.
|
31. |
Karakatsani A, Marichal N, Urban S, et al. Neuronal LRP4 regulates synapse formation in the developing CNS. Development, 2017, 144(24): 4604-4615.
|
32. |
Chakraborty S, Lakshmanan M, Swa HL, et al. An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma. Nat Commun, 2015, 6: 6184.
|
33. |
Hucz J, Kowalska M, Jarzab M, et al. Gene expression of meta-lloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer. Endokrynol Pol, 2006, 57 Suppl A: 18-25.
|
34. |
Zhou X, Xia E, Bhandari A, et al. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer. Biochem Biophys Res Commun, 2018, 503(1): 257-263.
|
35. |
Fischer P, Hilfiker-Kleiner D. Role of gp130-mediated signalling pathways in the heart and its impact on potential therapeutic aspects. Br J Pharmacol, 2008, 153 Suppl 1: S414-S427.
|
36. |
Elson GC, Lelièvre E, Guillet C, et al. CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nat Neurosci, 2000, 3(9): 867-872.
|
37. |
Knappskog PM, Majewski J, Livneh A, et al. Cold-induced sweating syndrome is caused by mutations in the CRLF1 gene. Am J Hum Genet, 2003, 72(2): 375-383.
|
38. |
Stearman RS, Dwyer-Nield L, Zerbe L, et al. Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model. Am J Pathol, 2005, 167(6): 1763-1775.
|
39. |
Yu ST, Zhong Q, Chen RH, et al. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways. Cell Death Dis, 2018, 9(3): 371.
|
40. |
Saito K, Ozawa Y, Hibino K, et al. FilGAP, a Rho/Rho-associated protein kinase-regulated GTPase-activating protein for Rac, controls tumor cell migration. Mol Biol Cell, 2012, 23(24): 4739-4750.
|
41. |
Morgan-Fisher M, Wewer UM, Yoneda A. Regulation of ROCK activity in cancer. J Histochem Cytochem, 2013, 61(3): 185-198.
|
42. |
Luo D, Chen H, Li X, et al. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma. Int J Oncol, 2017, 51(4): 1209-1218.
|
43. |
Su ZZ, Kang DC, Chen Y, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene, 2002, 21(22): 3592-3602.
|
44. |
Kang DC, Su ZZ, Sarkar D, et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene, 2005, 353(1): 8-15.
|
45. |
Yoo BK, Emdad L, Lee SG, et al. Astrocyte elevated gene-1 (AEG-1): A multifunctional regulator of normal and abnormal physiology. Pharmacol Ther, 2011, 130(1): 1-8.
|
46. |
Luo Y, Zhang X, Tan Z, et al. Astrocyte elevated gene-1 as a novel clinicopathological and prognostic biomarker for gastrointestinal cancers: a meta-analysis with 2 999 patients. PLoS One, 2015, 10(12): e0145659.
|
47. |
Emdad L, Das SK, Dasgupta S, et al. AEG-1/MTDH/LYRIC: signaling pathways, downstream genes, interacting proteins, and regulation of tumor angiogenesis. Adv Cancer Res, 2013, 120: 75-111.
|
48. |
Huang LL, Wang Z, Cao CJ, et al. AEG-1 associates with metastasis in papillary thyroid cancer through upregulation of MMP2/9. Int J Oncol, 2017, 51(3): 812-822.
|